
Orthofix Medical OFIX
$ 15.16
1.13%
Quarterly report 2025-Q3
added 11-04-2025
Orthofix Medical Interest Expense 2011-2025 | OFIX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Orthofix Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.62 M | -938 K | -3.15 M | -3.34 M | 8.38 M | -8.14 M | -6.38 M | -4 M | -2.81 M | -259 K | 1.78 M | 1.92 M | 4.58 M | 9.79 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.79 M | -9.62 M | -871 K |
Quarterly Interest Expense Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -535 K | 5.73 M | 1.25 M | - | -2.53 M | -2.51 M | -1.27 M | - | -2.36 M | -20 K | 676 K | - | -3.31 M | -3.19 M | -936 K | - | -1.79 M | 951 K | -2.69 M | - | 1.82 M | 5.07 M | -798 K | - | -8.15 M | -236 K | -404 K | - | -5.05 M | -3.64 M | 2.91 M | - | 479 K | 585 K | -4.35 M | - | -634 K | 147 K | 1.83 M | - | -1.74 M | 853 K | 272 K | - | 395 K | 492 K | 468 K | - | 539 K | 455 K | 560 K | - | 464 K | 1.26 M | 2.22 M | - | 2.27 M | 2.2 M | 2.42 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.73 M | -8.15 M | -218 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 96.13 | 0.04 % | $ 141 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.6 | - | $ 125 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 301.75 | 0.24 % | $ 8.51 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 48.12 | 0.21 % | $ 7.17 K | ||
|
Abbott Laboratories
ABT
|
376 M | $ 124.81 | 0.22 % | $ 217 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 2.97 | 4.58 % | $ 111 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.06 | 0.48 % | $ 1.23 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 63.08 | -0.27 % | $ 3.42 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.54 | - | $ 685 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 157.84 | 0.69 % | $ 11.8 B | ||
|
Myomo
MYO
|
21.1 K | $ 1.02 | 12.09 % | $ 7.19 M | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.86 | 0.43 % | $ 88.4 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 14.49 | 0.84 % | $ 392 M | ||
|
LENSAR
LNSR
|
660 K | $ 12.01 | -0.08 % | $ 138 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 14.53 | 0.07 % | $ 95.2 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.64 | -0.61 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 40.17 | 1.34 % | $ 1.24 B | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.41 | 0.75 % | $ 402 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 88.43 | -0.38 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.66 | 0.56 % | $ 975 M |